Nivalis Therapeutics Surrenders Early Gains
January 03, 2017 at 11:17 AM EST
Nivalis Therapeutics Inc (NASDAQ: NVLS) shares are trading higher by $0.02 at $2.26 in Tuesday's session. The issue has been ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.